Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C129825
Created by
admin on Wed Apr 02 08:43:52 GMT 2025 , Edited by admin on Wed Apr 02 08:43:52 GMT 2025
|
||
|
FDA ORPHAN DRUG |
433214
Created by
admin on Wed Apr 02 08:43:52 GMT 2025 , Edited by admin on Wed Apr 02 08:43:52 GMT 2025
|
||
|
NCI_THESAURUS |
C2167
Created by
admin on Wed Apr 02 08:43:52 GMT 2025 , Edited by admin on Wed Apr 02 08:43:52 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DEPATUXIZUMAB MAFODOTIN
Created by
admin on Wed Apr 02 08:43:52 GMT 2025 , Edited by admin on Wed Apr 02 08:43:52 GMT 2025
|
PRIMARY | |||
|
100000166799
Created by
admin on Wed Apr 02 08:43:52 GMT 2025 , Edited by admin on Wed Apr 02 08:43:52 GMT 2025
|
PRIMARY | |||
|
C105612
Created by
admin on Wed Apr 02 08:43:52 GMT 2025 , Edited by admin on Wed Apr 02 08:43:52 GMT 2025
|
PRIMARY | |||
|
CHEMBL3707277
Created by
admin on Wed Apr 02 08:43:52 GMT 2025 , Edited by admin on Wed Apr 02 08:43:52 GMT 2025
|
PRIMARY | |||
|
1585973-65-4
Created by
admin on Wed Apr 02 08:43:52 GMT 2025 , Edited by admin on Wed Apr 02 08:43:52 GMT 2025
|
PRIMARY | |||
|
CD-14
Created by
admin on Wed Apr 02 08:43:52 GMT 2025 , Edited by admin on Wed Apr 02 08:43:52 GMT 2025
|
PRIMARY | |||
|
F3R7A4P04N
Created by
admin on Wed Apr 02 08:43:52 GMT 2025 , Edited by admin on Wed Apr 02 08:43:52 GMT 2025
|
PRIMARY | |||
|
DB11731
Created by
admin on Wed Apr 02 08:43:52 GMT 2025 , Edited by admin on Wed Apr 02 08:43:52 GMT 2025
|
PRIMARY | |||
|
10263
Created by
admin on Wed Apr 02 08:43:52 GMT 2025 , Edited by admin on Wed Apr 02 08:43:52 GMT 2025
|
PRIMARY | |||
|
SUB181033
Created by
admin on Wed Apr 02 08:43:52 GMT 2025 , Edited by admin on Wed Apr 02 08:43:52 GMT 2025
|
PRIMARY |
ACTIVE MOIETY